Faeth Therapeutics Inc.
FTH | NASDAQ
$18.69
-$0.06 (-0.32%)
At close: Oct 30, 2026, 4:00 PM ET
$18.32
-$0.37 (-1.98%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Company Profile
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Key Executives
| Name | Position |
|---|---|
| Anand Parikh | CEO, President & Chair |
| Benjamin Hopkins | Scientific Co-Founder |
| Christopher Gerry | General Counsel & Secretary |
| Gregory J. Hannon | Scientific Co-Founder |
| Josiah Craver | Senior Vice President of Finance, Principal Financial Officer & Principal Accounting Officer |
| Karen H. Vousden | Scientific Co-Founder & Director |
| Lewis clayton Cantley | Scientific Co-Founder |
| Oliver Maddocks | Co-Founder & Chief Scientific Officer |
| Scott W. Lowe | Scientific Co-Founder |
| Siddhartha Mukherjee DPHIL | Scientific Co-Founder |
| Simon Knott | Scientific Co-Founder |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 17, 2026 | 8-K | Current Report |
| Sep 15, 2026 | 4 | Filing |
| Sep 15, 2026 | 3 | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 14, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 04, 2026 | 10-Q | Quarterly Report |
| Aug 04, 2026 | 8-K | Current Report |
| Jul 28, 2026 | 3 | Filing |
Faeth Therapeutics Inc.
| Country | United States |
| IPO Date | Feb 4, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 29 |
| CEO | Anand Parikh |
Contact Details
1405 Research Blvd Rockville,
Maryland 20850 United States
Stock Details
| Ticker Symbol | FTH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001829802 |
| CUSIP Number | 81728A207 |
| ISIN Number | US81728A2078 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove FTH